June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Identification of the hnRNPL and LOXL1-AS1 lncRNA complex: Implications for pathology in exfoliation glaucoma
Author Affiliations & Notes
  • William Marshall Johnson
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
  • Inas F Aboobakar
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
  • Laura Finnegan
    School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland
  • R Rand Allingham
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
    Singapore Eye Research Institute, Singapore National Eye Center, Singapore, Singapore, Duke, National University of Singapore, Singapore, Singapore
  • Michael A Hauser
    Departments of Ophthalmology and Medicine, Duke University Medical Center, Durham, North Carolina, United States
    Singapore Eye Research Institute, Singapore National Eye Center, Singapore, Singapore, Duke, National University of Singapore, Singapore, Singapore
  • W Daniel Stamer
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   William Johnson, None; Inas Aboobakar, None; Laura Finnegan, None; R Rand Allingham, None; Michael Hauser, None; W Daniel Stamer, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5590. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      William Marshall Johnson, Inas F Aboobakar, Laura Finnegan, R Rand Allingham, Michael A Hauser, W Daniel Stamer; Identification of the hnRNPL and LOXL1-AS1 lncRNA complex: Implications for pathology in exfoliation glaucoma. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5590.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Exfoliation glaucoma (XFG) is a clinically aggressive and genetically distinct form of glaucoma caused by extrafibullary material deposition in the trabecular meshwork, leading to increased intraocular pressure and death of retinal ganglion cells. Gene variants located in the promoter of a novel long non coding RNA (lncRNA), LOXL1-AS1 associate with XFG risk. Since lncRNAs can impact susceptibility to disease through alterations in gene expression, we investigated the downstream targets of LOXL1-AS1.

Methods : RNAseq was performed on cDNA derived from an immortalized lens epithelial cell line (B-3) after RNAi knockdown of LOXL1-AS1 or scrambled control to identify differentially expressed RNAs. To identify LOXL1-AS1 binding partners, we incubated biotinylated LOXL1-AS1 or control RNA with nuclear lysates followed by a pulldown using streptavidin beads. Proteins were resolved by SDS-PAGE, and identified through analysis of mass spectrometry data. Recombinant protein candidates and LOXL1-AS1 were incubated and immunoprecipitated in vitro to test direct binding and confirm mass spectrometry results.

Results : RNAseq identified 88 significantly altered RNAs, including 14 lncRNAs using parameters of logFC +/- 1.5 and P < 0.0001. Notably, several altered RNAs were filamentous/extracellular matrix proteins or involved in ECM homeostasis including INA, KRT14, and MMP9. To assess the mechanism by which LOXL1-AS1 alters gene expression, mass spectrometry revealed that LOXL1-AS1 interacts with the RNA processing proteins hnRNPL and ERF3A. Using protein/RNA binding studies, we demonstrated the direct binding of hnRNPL to LOXL1-AS1, through a 14 bp region in LOXL1-AS1. Conversely ERF3A, which was also identified by the mass spectrometry screen, bound to both LOXL1-AS1 and a complement RNAs indicating limited sequence specificity (false positive).

Conclusions : We observed that LOXL1-AS1 regulates a specific subset of target RNAs, and that this regulation may occur through interaction with hnRNPL. These findings strengthen the hypothesis that LOXL1-AS1 is a key player in XFG pathology and that targeting of the LOXL1-AS1/hnRNPL complex may provide novel therapeutic strategies for XFG.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×